Our project Sweet-19 from Bulgaria is to develop multi-component product on herb base for those, who suffer from COVID-19 , helping to overcome of the negative consequences for the lungs from the infection, using synergy acting combination of components, (including Bulgarian Rose and others - https://www.ncbi.nlm.nih.gov/pubmed/8954085 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4737971/ ) , containing bio-active substances, a subject of different medical researches and publications, including from 2 of our team members Phd researchers .(See their publications for one of the main ingredients in Sweet-19 here: www.siriusart.bg/GeraniumS.-article1.pdf , www.siriusart.bg/murzakhmetova2008-ANTIOXIDANT.pdf - published in Phytotherapy Research and Toxicology Letters )
Sweet-19 contains 19 natural ingredients with antiviral, antioxidant, anti-inflammatory, expectorant, immune-stimulating and lung-mitigating effect, combined to achieve boosted recovery from the infection in synergy.
Covid-19 infection is considered as root cause for many other social and economic problems and boosting recovery from the infection could have positive effect in different areas - for example for business - more active employees, more active healthcare personal, to lower the pressure over the hospitals and over the national healthcare finances, considering the relatively low price for one treatment procedure - up to 3 packs of Sweet-19, 90 capsules - up to 30 EUR per patient (or less)
We target B2B business model for a product with global market with growth - According to the current analysis of Reports and Data, the global antiviral drugs market was valued at USD 49.87 billion in 2018 and is expected to reach USD 71.48 billion by year 2026, at a CAGR of 4.6%.
Our product is passed its developments stage and we preparing for production - by using facilities for production and packaging of existing pharmaceutical companies, distribution by wholesale pharmaceutical distributors.
We already issued documents for registration in the Bulgarian Food Safety Agency and this can give us EU-wide license. It is planned production to start in the beginning of July - with focus and strategy for sustainable development.
Strong side for the project is our Multi-disciplinary team:
- Dimo Mitchev - serial entrepreneur with BS of entrepreneurship, MD undergraduate in Innovations with practical experience in business
- Phd Silvia Abarova, Sofia Medical University, lead of laboratory of Nanotechnology in the medicine
- Professor Phd Lubka Tancheva, Bulgarian Academy of Science
We joined efforts and this is our response for the crisis - helping to save life by using natural non-toxic ingredients, supported by medical researches, and soon the product to be on the market.
For now we bootstrapping and invest our own money in the product development, but also look for partners and support in order to help as much as possible people.